Afluria is indicated for active immunization of person ages 18 years and older against influenza disease caused by influenza virus subtype A and type B present in the vaccine.
Afluria Southern Hemisphere is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.
Afluria Southern Hemisphere is approved for use in persons 6 months of age and older.
Product Information
Supporting Documents
Related Information
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
